Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cour Pharmaceuticals Development — Funding & Investors." VCBacked, January 30, 2024, https://www.vcbacked.co/company/cour-pharmaceuticals-development. Accessed June 17, 2026.
VCBacked. (2024). Cour Pharmaceuticals Development — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/cour-pharmaceuticals-development
{{cite web |title=Cour Pharmaceuticals Development — Funding & Investors |url=https://www.vcbacked.co/company/cour-pharmaceuticals-development |website=VCBacked |access-date=June 17, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .